Post by Syntegon

113,567 followers

What’s fuelling growth in the liquid vial market?​ Two very different types of medicines.​ Blockbuster therapies like vaccines demand speed and high-output fill-finish lines to meet global volumes.​ At the same time, biopharmaceuticals and antibody-drug conjugates, often used in oncology and gene therapy, are smaller batch, highly specialized, and require flexible equipment to handle varying vial types, viscosities, and sensitivities.​ Add stricter regulations, including the revised EU GMP Annex 1, and the need is clear: fill-finish solutions must balance efficiency with adaptability.​ At Syntegon, we deliver scalable, compliant fill-finish solutions built for a changing market, ready to empower your entire lifecycle.​ #COCREATE #COSUCCEED #Syntegon #LifecyclePartner

Post content

Video Content